MARC details
000 -LEADER |
fixed length control field |
02512cam a2200445Mi 4500 |
001 - CONTROL NUMBER |
control field |
on1046084832 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20210921181123.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
fixed length control field |
m |o d| |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr |n||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
170131s2009 nyu |o 000|0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781420073188 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781420073188: |
Terms of availability |
No price |
029 0# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
AU@ |
System control number |
000062492190 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1046084832 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
AU@ |
Language of cataloging |
eng |
Description conventions |
rda |
-- |
pn |
Transcribing agency |
AU@ |
Modifying agency |
OCLCO |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Gibson, Mark. |
Relator term |
author. |
245 10 - TITLE STATEMENT |
Title |
Pharmaceutical preformulation and formulation : |
Remainder of title |
a practical guide from candidate drug selection to commercial dosage form : |
Medium |
[electronic book] / |
250 ## - EDITION STATEMENT |
Edition statement |
2nd edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
CRC Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2009. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource (560 pages). |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
337 ## - MEDIA TYPE |
Media type term |
computer |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Source |
rdacarrier |
490 1# - SERIES STATEMENT |
Series statement |
Drugs and the Pharmaceutical Sciences ; |
Volume/sequential designation |
v.199. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preface -- Contributors -- Introduction and perspective -- Aiding candidate drug selection : introduction and objectives -- Preformulation investigations using small amounts of compound as an aid to candidate drug selection and early development -- Biopharmaceutical support in candidate drug selection -- Early drug development : product design -- Preformulation as an aid to product design in early drug development -- Biopharmaceutical support in formulation development -- Product optimization -- Parenteral dosage forms -- Inhalation dosage forms -- Oral solid dosage forms -- Ophthalmic dosage forms -- Aqueous nasal dosage forms -- Topical and transdermal delivery. |
520 8# - SUMMARY, ETC. |
Summary, etc. |
This second edition reflects the mounting pressure on pharmaceutical companies to accelerate the new drug development & launch process, & the shift from developing small molecules to the growth of biopharmaceuticals. It meets the need for up-to-date & advanced information for drug preformulation & formulation. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Biopharmaceutics. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Dosage forms. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical chemistry. |
710 ## - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
EBSCO |
Relator term |
vendor |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Drugs and the pharmaceutical sciences. |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,sso&db=nlebk&AN=291749&site=ehost-live&custid=s7813921">https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,sso&db=nlebk&AN=291749&site=ehost-live&custid=s7813921</a> |
Public note |
Access ebook here |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
EBSCO Ebook |
Suppress in OPAC |
0 |
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN) |
h (OCLC) |
NO HOLDINGS IN LQI - 1 OTHER HOLDINGS |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
Local |
n |